Stay updated on Autologous BCMA CAR T-cells in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Autologous BCMA CAR T-cells in Myeloma Clinical Trial page.

Latest updates to the Autologous BCMA CAR T-cells in Myeloma Clinical Trial page
- Check4 days agoChange DetectedNew revision entry v3.3.4 was added and v3.3.3 removed in the Record History for NCT03448978; this is metadata related to record-keeping and does not affect study data or user-facing content, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded a new Record History entry: Revision: v3.3.3. The page also removed the HHS Vulnerability Disclosure link and the previous Revision: v3.3.2 entry; these are maintenance updates with no impact on study content.SummaryDifference0.2%

- Check54 days agoChange DetectedRecord history shows a new release revision v3.3.2 added and the previous revision v3.2.0 removed.SummaryDifference0.1%

- Check61 days agoChange DetectedRemoved the notice about government funding lapse and potential data delays; the page now directs users to opm.gov for operating status updates (To avoid being alerted by small changes, set an alert condition by clicking below).SummaryDifference0.7%

- Check75 days agoChange DetectedThe new screenshot shows a refreshed header and styling on the Record History page, while the list of version entries and their dates remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check104 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference12%

Stay in the know with updates to Autologous BCMA CAR T-cells in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Autologous BCMA CAR T-cells in Myeloma Clinical Trial page.